Thamires Oliveira Silva Received the 2025 Young Investigator Award – IASLC
International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“Congrats to Dr. Thamires Oliveira Silva at D’Or Institute for Research and Education!
One of our 2025 Young Investigator Awardees!
Their project, Genome-wide DNA Methylation Analysis in Patients with EFGFR-mutant Lung Adenocarcinoma, investigates whether specific DNA methylation patterns in EGFR-mutated NSCLC define prognostic subgroups and influence response to third-generation TKIs such as osimertinib. By analyzing tumor methylomes, we aim to identify patients with intrinsic resistance despite sensitizing EGFR mutations. Findings may inform personalized treatment strategies, refine escalation/de-escalation decisions, and advance precision medicine in thoracic oncology.
We’re excited to see where this research leads, way to go, Dr. Silva!”
More posts featuring IASLC on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023